Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

WC Wei, CC Liaw, KC Tsai, CT Chiou, YH Tseng… - Pharmacological …, 2022 - Elsevier
The global COVID-19 pandemic remains a critical public health threat, as existing vaccines
and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to …
被引用次数：19 相关文章

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

WC Wei, CC Liaw, KC Tsai, CT Chiou… - Pharmacological …, 2022 - pubmed.ncbi.nlm.nih.gov
The global COVID-19 pandemic remains a critical public health threat, as existing vaccines
and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to …
[HTML] nih.gov

[HTML][HTML] Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

WC Wei, CC Liaw, KC Tsai, CT Chiou… - Pharmacological …, 2022 - ncbi.nlm.nih.gov
The global COVID-19 pandemic remains a critical public health threat, as existing vaccines
and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to …

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis.

WC Wei, CC Liaw, KC Tsai, CT Chiou… - Pharmacological …, 2022 - europepmc.org
The global COVID-19 pandemic remains a critical public health threat, as existing vaccines
and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to …

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

WC Wei, CC Liaw, KC Tsai… - Pharmacological …, 2022 - researchoutput.ncku.edu.tw
The global COVID-19 pandemic remains a critical public health threat, as existing vaccines
and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to …

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis.

WC Wei, CC Liaw, KC Tsai, CT Chiou… - Pharmacological …, 2022 - europepmc.org
The global COVID-19 pandemic remains a critical public health threat, as existing vaccines
and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to …